Stehman-Breen Catherine 4
4 · Dyne Therapeutics, Inc. · Filed Jun 6, 2022
Insider Transaction Report
Form 4
Stehman-Breen Catherine
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-03+19,596→ 19,596 totalExercise: $4.58Exp: 2032-06-02→ Common Stock (19,596 underlying)
Footnotes (1)
- [F1]This option was granted on June 3, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 3, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders.